Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Compare total market funds to determine which has the lowest fees, balancing expense ratios with diversification and performance history.
28,601 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
As costs rise, actions at ages 63 and 64 become a deciding factor for Medicare premiums at 65. IRMAA surcharges drive...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
Broker Public Portal and Realtors Property Resource unveiled a staged integration of the Realtors Valuation Model int...
Independent single-family rental owners are largely insulated from institutional competition, according to TurboTenan...
Zillow filed an antitrust suit against MRED and Compass, raising the question of whether a real estate data platform ...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
Cardano’s ADA traded near the 26-cent mark as regulators named ADA a digital commodity, boosting optimism while price...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Micron Technology posted a robust quarter fueled by AI infrastructure spending, signaling a multi-year path for this ...
Marvell Technology extended a dramatic rally, up 45% in a month on record revenue, while investors weigh whether to t...